We use cookies to analyze site usage and improve your experience. You can accept all, reject non-essential, or customize. See our Privacy Policy.
Reference sheet · Kinase Substrates · CPC catalog code PKCP-019
Full physicochemical data (sequence, molecular formula, molecular weight, CAS) is documented on the upstream certificate of analysis. Request the current lot COA from the supplier before use — values may vary between manufacturing runs.
Reference standards in the Kinase Substrates class are typically shipped as lyophilized powder and stored desiccated at −20 °C protected from light. Once reconstituted in bacteriostatic water or the assay-appropriate buffer, aliquot and store at −80 °C to minimize freeze–thaw cycles. Confirm handling requirements against your institutional biosafety and radiation protocols before use.
Myosin Kinase Inhibiting Peptide sits within the Kinase Substrates research class (CPC reference PKCP-019). These peptides carry consensus phosphorylation motifs recognized by specific kinase families (PKA, PKC, CDK, MAPK, tyrosine kinases). Phosphorylation is detected via radiolabel incorporation, ADP quantitation, or antibody-based readouts. Investigators typically incorporate Myosin Kinase Inhibiting Peptide as a reference standard, tool ligand, or substrate in the assay contexts listed above. ADP-Glo, HTRF KinEASE, and radiometric filter-binding assays.
Myosin Kinase Inhibiting Peptide (CPC catalog code PKCP-019) is a synthetic kinase / phosphatase substrate in the kinase substrates category. It is provided as a lyophilized ~1 mg vial for in-vitro research use only.
Published and internal research programs use Myosin Kinase Inhibiting Peptide as a reference standard in kinase substrates workflows — for example, kinase activity and kinetic characterization and high-throughput inhibitor screening. Human clinical evidence is not established.
No. Myosin Kinase Inhibiting Peptide is a research-grade reference peptide and is not approved by the FDA or any national regulator for human or veterinary therapeutic use. It is offered exclusively for in-vitro laboratory research and does not ship to the United States for consumer use.
In a kinase substrates workflow, Myosin Kinase Inhibiting Peptide is reconstituted in sterile buffer or DMSO (solubility-dependent) and applied in the researcher's chosen assay format. ADP-Glo, HTRF KinEASE, and radiometric filter-binding assays.
Other reference standards in the same class — commonly cross-referenced during assay design and comparator selection.